Biogen agreed to pay US$300 million upfront and as much as a further US$410 million in milestone payments for BMS-986168, a Phase-2 ready drug in development for progressive supranuclear palsy (PSP).
See: (Hottod here)
While I'm still not inclined to believe the cards will fall in favour of a licence: I just don't think a Pharma will hand us big bucks to parlay NNZ 2591 (possibly the superior to the NNZ 2566 molecule, and certainly superior in the bioavailability stakes) into a gen 2 competitor.
So my leaning is to a buy-out - let's park that. I try to look beyond my assumptions and biases yada yada....
The quote above from a favoured correspondent makes a simple evidenced based assertion (read that post it's a cracker...btw) about the potential size of a deal.
And I want to pare it back to one key figure and ask what are reasonable projections to our share price?
Premise: Treagus delivers a US $300 million up front - stop there - let's say it is a licence after all...my assumption is that means that NEU gets a payment of approximately AUD $390 million. And for that, Trofinetide is with a partner, promises of royalties....etc.
If NEU had that AUD $390 million in the bank, disregarding, for now, the promise of future success and royalties, what would you put the share price at?
- Forums
- ASX - By Stock
- An Up Front...
Biogen agreed to pay US$300 million upfront and as much as a...
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.10 |
Change
-0.110(0.54%) |
Mkt cap ! $2.569B |
Open | High | Low | Value | Volume |
$20.16 | $20.21 | $19.88 | $5.839M | 291.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1042 | $20.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.11 | 1092 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1042 | 20.020 |
2 | 1438 | 20.000 |
2 | 2193 | 19.970 |
1 | 1038 | 19.960 |
2 | 3733 | 19.950 |
Price($) | Vol. | No. |
---|---|---|
20.140 | 773 | 1 |
20.170 | 1340 | 1 |
20.200 | 2000 | 1 |
20.210 | 2080 | 3 |
20.250 | 1289 | 2 |
Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |